The Role of Genetic Counseling in Pompe Disease After Patients Are Identified Through Newborn Screening

Andrea M Atherton1, Debra Day-Salvatore2,

  • 1Children's Mercy Hospital, Kansas City, Missouri; and.

Pediatrics
|November 23, 2017
PubMed

Insights

Genetic counseling is crucial for Pompe disease patients and families, offering vital information on inheritance, risks, and treatments. Standardized practices are needed to ensure informed decision-making and comprehensive care for all diagnosed individuals.

Area of Science:

  • Medical Genetics
  • Rare Diseases
  • Genetic Counseling

Background:

  • Pompe disease requires coordinated care, with genetic counseling being a key component for all patients.
  • Understanding the role and establishing consistent practices for genetic counseling in Pompe disease is currently lacking.
  • Genetic counseling aids families in comprehending medical information and making informed decisions regarding Pompe disease management.

Purpose of the Study:

  • To provide guidance on genetic counseling for Pompe disease, particularly for those identified through newborn screening (NBS).
  • To clarify the role of genetic counseling for families and healthcare teams involved in Pompe disease care.
  • To establish a framework for standardized genetic counseling practices for patients and at-risk family members.

Main Methods:

  • Expert consensus from the Pompe Disease Newborn Screening Working Group.
  • Development of guidance for genetic counseling practices in the context of Pompe disease diagnosis and management.
  • Focus on information dissemination regarding inheritance, genetic risks, treatments, and resources.

Main Results:

  • The guidance aims to standardize genetic counseling for Pompe disease patients and families.
  • It addresses special considerations, including early diagnosis of late-onset Pompe disease and implications of genetic risk assessment.
  • The framework supports informed decision-making for patients, carriers, and at-risk relatives.

Conclusions:

  • Genetic counseling is essential for comprehensive Pompe disease care, regardless of diagnosis method (NBS, clinical, prenatal).
  • Standardized genetic counseling practices are necessary to support patients, families, and healthcare providers.
  • This guidance provides a framework to improve understanding and implementation of genetic counseling for Pompe disease.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.9K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
20
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
19